Jeong Doo Heo Selected Research

KRC-108

7/2022

Characterization of KRC-108 as a TrkA Kinase Inhibitor with Anti-Tumor Effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeong Doo Heo Research Topics

Disease

11	Neoplasms (Cancer) 07/2022 - 09/2015
8	Stomach Neoplasms (Stomach Cancer) 04/2021 - 09/2015
7	Inflammation (Inflammations) 06/2022 - 09/2016
3	Neoplasm Metastasis (Metastasis) 08/2021 - 02/2017
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2020 - 01/2018
3	AIDS-Related Complex (ARC) 12/2013 - 09/2007
2	Hepatocellular Carcinoma (Hepatoma) 08/2021 - 02/2017
2	Adenocarcinoma 07/2017 - 09/2015
1	Colonic Neoplasms (Colon Cancer) 07/2022
1	COVID-19 06/2022
1	Sarcopenia 03/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2021
1	Thyroid Neoplasms (Thyroid Cancer) 01/2021
1	Leukemia 06/2020
1	Pneumonia (Pneumonitis) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2017
1	Lymphoma (Lymphomas) 04/2017
1	Wounds and Injuries (Trauma) 02/2017
1	Alzheimer Disease (Alzheimer's Disease) 09/2016
1	Hepatoblastoma 12/2015
1	Carcinoma (Carcinomatosis) 09/2015
1	Atopic Dermatitis (Atopic Eczema) 01/2015
1	Dermatitis 01/2015

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 07/2022 - 02/2017
7	FlavonoidsIBA 01/2020 - 12/2015
4	scutellareinIBA 06/2022 - 01/2018
3	Biological ProductsIBA 08/2021 - 09/2015
3	Biomarkers (Surrogate Marker)IBA 03/2021 - 12/2018
3	Pharmaceutical PreparationsIBA 03/2021 - 11/2019
3	MetalsIBA 12/2013 - 09/2007
3	Stainless Steel (Steel, Stainless)IBA 12/2013 - 09/2007
2	Phosphotransferases (Kinase)IBA 07/2022 - 01/2021
2	CytokinesIBA 06/2022 - 01/2015
2	flavoneIBA 08/2021 - 01/2020
2	tyrosine receptor (receptor, tyrosine)IBA 06/2020 - 01/2018
2	pectolinarigeninIBA 10/2018 - 08/2018
2	CaspasesIBA 01/2018 - 04/2017
1	KRC-108IBA 07/2022
1	Phospholipases (Phospholipase)IBA 07/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2022
1	Mitogen-Activated Protein KinasesIBA 06/2022
1	LipopolysaccharidesIBA 06/2022
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2022
1	EndotoxinsIBA 06/2022
1	Peptides (Polypeptides)IBA 10/2020
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2020
1	fms-Like Tyrosine Kinase 3IBA 05/2019
1	Ligases (Synthetase)IBA 01/2019
1	Volatile Oils (Essential Oils)IBA 01/2019
1	Terpenes (Terpenoids)IBA 01/2019
1	UbiquitinIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	tangeretinIBA 12/2018
1	Cytotoxins (Cytolysins)IBA 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2017
1	IgA receptor (protein B)IBA 04/2017
1	Matrix Metalloproteinases (MMPs)IBA 02/2017
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 02/2017
1	Ergocalciferols (Ergocalciferol)FDA LinkGeneric 09/2016
1	GlycosidesIBA 09/2015
1	flavanoneIBA 09/2015
1	poncirinIBA 09/2015
1	AntioxidantsIBA 09/2015
1	Fas Ligand Protein (Fas Ligand)IBA 09/2015
1	naringinIBA 09/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2015
1	Immunoglobulin E (IgE)IBA 01/2015
1	Polysaccharides (Glycans)IBA 01/2015

Therapy/Procedure

4	Therapeutics 08/2021 - 01/2018
1	Aftercare (After-Treatment) 08/2021
1	Oral Administration 01/2021
1	Intravenous Administration 01/2018